Short Term Trade Idea Buy (CIPLA)
Health Care
Pharmaceuticals
Largecap
With a market cap of ₹88,870 cr, stock is ranked 60
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Disclaimer : I am not a SEBI Registered Research Analyst so before your Investment Please Consult you Financial adviser.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。